A Mount Sinai-led team of researchers has enhanced an artificial intelligence (AI)-powered algorithm to analyze video recordings of clinical sleep tests, ultimately improving accurate diagnosis of a common sleep disorder affecting more than 80 million people worldwide.
FDA rejects Eli Lilly’s eczema drug due to third-party manufacturing issues
FDA has rejected Eli Lilly’s eczema treatment lebrikizumab due to issues found at an unnamed third-party manufacturer. According to a press release, a “multi-sponsor” inspection